Expertise in
13
conditions

Dr. Mohamed M. Hegazi

Internal Medicine
UofL Health – Brown Cancer Center – Blood Cancer, Cellular Therapeutics And Transplant Program
550 S Jackson St, 
Louisville, KY 
Accepting New Patients
Expertise in
13
conditions
UofL Health – Brown Cancer Center – Blood Cancer, Cellular Therapeutics And Transplant Program
550 S Jackson St, 
Louisville, KY 

Overview

Mohamed Hegazi is a primary care provider, practicing in Internal Medicine in Louisville, Kentucky.

Dr. Hegazi is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), Smoldering Multiple Myeloma, Bone Marrow Aspiration, and Endoscopy.

He is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 4 clinical trials. Dr. Hegazi is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in KY

Hospital Affiliations

University Of Louisville Hospital
Norton Hospitals, Inc
UOFL HEALTH - JEWISH HOSPITAL And Mary & Elizabeth Hospital
Baptist Health Louisville

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

UofL Health – Brown Cancer Center – Blood Cancer, Cellular Therapeutics and Transplant Program
550 S Jackson St, Louisville, KY 40202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction With Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) in Adults
A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction With Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) in Adults
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Procedure, Biological
Study Drugs: Blinatumomab, Cyclophosphamide, Cytarabine, Dasatinib, Dexamethasone, Doxorubicin Hydrochloride, Mesna, Methotrexate, Ponatinib Hydrochloride, Prednisone, Vincristine Sulfate
Study Phase: Phase 3
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Drug, Procedure, Biological
Study Drugs: Blinatumomab, Cyclophosphamide, Cytarabine, Daunorubicin, Daunorubicin Hydrochloride, Dexamethasone, Etoposide, Mercaptopurine, Methotrexate, Pegaspargase, Prednisone, Rituximab, Vincristine, Vincristine Sulfate
Study Phase: Phase 3
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Drug, Other, Procedure
Study Drugs: Carmustine, Cyclophosphamide, Cytarabine, Etoposide, Ibrutinib, Melphalan
Study Phase: Phase 3
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Lenalidomide, Daratumumab/rHuPH20
Study Phase: Phase 3
View 3 Less Clinical Trials

7 Total Publications

Awareness of disease extent and perceived palliative treatment goals among oncology patients: a multicenter study.
Awareness of disease extent and perceived palliative treatment goals among oncology patients: a multicenter study.
Journal: Scientific reports
Published: March 14, 2026
Similar Doctors
Expertise in
155
conditions
Dr. Patricia J. Hansen
Internal Medicine
Expertise in
155
conditions
Dr. Patricia J. Hansen
Internal Medicine

Norton Community Medical Associates - Audubon

3101 Poplar Level Road, Suite 101, 
Louisville, KY 
 (5.1 miles away)
502-636-7444
Languages Spoken:
English, Spanish
See accepted insurances

Patricia Hansen is a primary care provider, practicing in Internal Medicine in Louisville, Kentucky. Dr. Hansen is highly rated in 155 conditions, according to our data. Her clinical expertise encompasses High Cholesterol, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Endoscopy. Dr. Hansen is board certified in American Board Of Internal Medicine, Internal Medicine - 1996.

Expertise in
60
conditions
Dr. Suresh G. Nair
Internal Medicine
Expertise in
60
conditions
Dr. Suresh G. Nair
Internal Medicine

First Urology PSC

8442 Dixie Hwy, 
Louisville, KY 
 (10.0 miles away)
502-638-4280
Languages Spoken:
English
See accepted insurances

Suresh Nair is a primary care provider, practicing in Internal Medicine in Louisville, Kentucky. Dr. Nair is highly rated in 60 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Coronary Artery Bypass Graft (CABG), and Gastrostomy.

Expertise in
20
conditions
Dr. Frank T. Simon
Internal Medicine
Expertise in
20
conditions
Dr. Frank T. Simon
Internal Medicine

Louisville-Jefferson County Metro Government

2215 Portland Ave, 
Louisville,, KY 
 (2.6 miles away)
502-774-8631
Languages Spoken:
English
See accepted insurances

Frank Simon is a primary care provider, practicing in Internal Medicine in Louisville,, Kentucky. Dr. Simon is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Grass Allergy, Empyema, Sinusitis, and Allergic Rhinitis.

Frequently Asked Questions about Dr. Mohamed M. Hegazi

How do I make an appointment with Dr. Mohamed M. Hegazi?

You can book an appointment with Dr. Mohamed M. Hegazi by calling their office at 502-562-4266. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mohamed M. Hegazi a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mohamed M. Hegazi is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mohamed M. Hegazi specialize in?

While Dr. Mohamed M. Hegazi is a Internal Medicine, they have specific expertise in Multiple Myeloma, Chronic Lymphocytic Leukemia (CLL), and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Mohamed M. Hegazi participate in research or clinical trials?

Yes. Dr. Mohamed M. Hegazi has published 7 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Mohamed M. Hegazi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mohamed M. Hegazi accept my insurance?

Dr. Mohamed M. Hegazi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 502-562-4266 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hegazi's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 73 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile